Unknown

Dataset Information

0

Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.


ABSTRACT:

Scope

Sphingolipids including ceramides are implicated in the pathogenesis of obesity and insulin resistance. Correspondingly, inhibition of pro-inflammatory and neurotoxic ceramide accumulation prevents obesity-mediated insulin resistance and cognitive impairment. Increasing evidence suggests the farnesoid X receptor (FXR) is involved in ceramide metabolism, as bile acid-FXR crosstalk controls ceramide levels along the gut-liver axis. The authors previously reported that FXR agonist xanthohumol (XN), the principal prenylated flavonoid in hops (Humulus lupulus), and its hydrogenated derivatives, α,β-dihydroxanthohumol (DXN), and tetrahydroxanthohumol (TXN), ameliorated obesity-mediated insulin resistance, and cognitive impairment in mice fed a high-fat diet.

Methods and results

To better understand how the flavonoids improve both, lipid and bile acid profiles in the liver are analyzed, sphingolipid relative abundance in the hippocampus is measured, and linked them to metabolic and neurocognitive performance. XN, DXN, and TXN (30 mg kg-1 BW per day) decrease ceramide content in liver and hippocampus; the latter is linked to improvements in spatial learning and memory. In addition, XN, DXN, and TXN decrease hepatic cholesterol content by enhancing de novo synthesis of bile acids.

Conclusion

These observations suggest that XN, DXN, and TXN may alleviate obesity-induced metabolic and neurocognitive impairments by targeting the liver-brain axis.

SUBMITTER: Paraiso IL 

PROVIDER: S-EPMC8693899 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Targeting the Liver-Brain Axis with Hop-Derived Flavonoids Improves Lipid Metabolism and Cognitive Performance in Mice.

Paraiso Ines L IL   Revel Johana S JS   Choi Jaewoo J   Miranda Cristobal L CL   Lak Parnian P   Kioussi Chrissa C   Bobe Gerd G   Gombart Adrian F AF   Raber Jacob J   Maier Claudia S CS   Stevens Jan F JF  

Molecular nutrition & food research 20200706 15


<h4>Scope</h4>Sphingolipids including ceramides are implicated in the pathogenesis of obesity and insulin resistance. Correspondingly, inhibition of pro-inflammatory and neurotoxic ceramide accumulation prevents obesity-mediated insulin resistance and cognitive impairment. Increasing evidence suggests the farnesoid X receptor (FXR) is involved in ceramide metabolism, as bile acid-FXR crosstalk controls ceramide levels along the gut-liver axis. The authors previously reported that FXR agonist xan  ...[more]

Similar Datasets

| S-EPMC8572884 | biostudies-literature
| S-EPMC11582619 | biostudies-literature
| S-EPMC8944850 | biostudies-literature
| S-EPMC7369117 | biostudies-literature
| S-EPMC6984781 | biostudies-literature
| S-EPMC4185346 | biostudies-literature
| S-EPMC11806572 | biostudies-literature
| S-EPMC9817797 | biostudies-literature
| S-EPMC9499015 | biostudies-literature
| S-EPMC11369409 | biostudies-literature